Montenarh M - Search Results

1

Analysis of the immunoreactivity of three anti-p53 antibodies and estimation of the relations between p53 status and MDM2 protein expression in ovarian carcinomas.

Harlozińska A, Bar J, Montenarh M. Harlozińska A, et al. Among authors: montenarh m. Anticancer Res. 2000 Mar-Apr;20(2A):1049-56. Anticancer Res. 2000. PMID: 10810396

2

Temperature-sensitive ovarian carcinoma cell line (OvBH-1).

Bar JK, Harlozinska A, Kartarius S, Montenarh M, Wyrodek E, Parkitna JM, Kochman M, Ozyhar A. Bar JK, et al. Among authors: montenarh m. Jpn J Cancer Res. 2002 Sep;93(9):976-85. doi: 10.1111/j.1349-7006.2002.tb02473.x. Jpn J Cancer Res. 2002. PMID: 12359050 Free PMC article.

3

Relations between immunologically different p53 forms, p21(WAF1) and PCNA expression in ovarian carcinomas.

Harlozinska A, Bar JK, Montenarh M, Kartarius S. Harlozinska A, et al. Among authors: montenarh m. Oncol Rep. 2002 Nov-Dec;9(6):1173-9. Oncol Rep. 2002. PMID: 12375014

4

Cytogenetic and molecular cytogenetic characterization of the stable ovarian carcinoma cell line (OvBH-1).

Schlade-Bartusiak K, Sasiadek MM, Bar JK, Urbschat S, Blin N, Montenarh M, Harłozińska-Szmyrka A. Schlade-Bartusiak K, et al. Among authors: montenarh m. Cancer Genet Cytogenet. 2006 Jan 1;164(1):10-5. doi: 10.1016/j.cancergencyto.2005.04.011. Cancer Genet Cytogenet. 2006. PMID: 16364757

5

p53 autoantibodies in the sera, cyst and ascitic fluids of patients with ovarian cancer.

Montenarh M, Harloziñska A, Bar JK, Kartarius S, Günther J, Sedlaczek P. Montenarh M, et al. Int J Oncol. 1998 Sep;13(3):605-10. doi: 10.3892/ijo.13.3.605. Int J Oncol. 1998. PMID: 9683801

6

Growth inhibition and apoptosis induction in ovarian cancer cells.

Touma R, Kartarius S, Harlozinska A, Götz C, Montenarh M. Touma R, et al. Among authors: montenarh m. Int J Oncol. 2006 Aug;29(2):481-8. Int J Oncol. 2006. PMID: 16820892

7

Serum anti-p53 antibodies in patients with lung cancer.

Mack U, Ukena D, Montenarh M, Sybrecht GW. Mack U, et al. Among authors: montenarh m. Oncol Rep. 2000 May-Jun;7(3):669-74. doi: 10.3892/or.7.3.669. Oncol Rep. 2000. PMID: 10767388

8

Antibodies against murine double minute-2 (mdm2) in sera of patients with various gynaecological diseases.

Selter H, Amela-Neuschwander S, Villena-Heinsen C, Montenarh M. Selter H, et al. Among authors: montenarh m. Cancer Lett. 1995 Sep 4;96(1):111-5. doi: 10.1016/0304-3835(95)03920-r. Cancer Lett. 1995. PMID: 7553598

9

Identification of a CK2 phosphorylation site in mdm2.

Götz C, Kartarius S, Scholtes P, Nastainczyk W, Montenarh M. Götz C, et al. Among authors: montenarh m. Eur J Biochem. 1999 Dec;266(2):493-501. doi: 10.1046/j.1432-1327.1999.00882.x. Eur J Biochem. 1999. PMID: 10561590 Free article.

10

Wild-type p53 inhibits protein kinase CK2 activity.

Schuster N, Götz C, Faust M, Schneider E, Prowald A, Jungbluth A, Montenarh M. Schuster N, et al. Among authors: montenarh m. J Cell Biochem. 2001;81(1):172-83. doi: 10.1002/1097-4644(20010401)81:1<172::aid-jcb1033>3.0.co;2-o. J Cell Biochem. 2001. PMID: 11180407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters